Why the study?
MICS CABG through left anterior mini-thoracotomy avoids extracorporeal circulation and sternotomy, but its adoption remains limited and long-term outcomes in large cohorts required evaluation.
Does minimally invasive multi-vessel off-pump coronary artery bypass grafting provide safe and effective long-term outcomes in eligible patients?
Does minimally invasive multi-vessel off-pump coronary artery bypass grafting provide safe and effective long-term outcomes in eligible patients?
Minimally invasive multi-vessel off-pump coronary artery bypass grafting is a safe and effective revascularisation strategy with low early complications and an 80% survival rate at 10 years.
Supports MICS CABG durability in selected patients at expert centers; leaves open head-to-head trials versus conventional CABG.
Background: Minimally invasive multi-vessel off-pump coronary artery bypass grafting (MICS CABG) through left anterior mini-thoracotomy avoids both extracorporeal circulation and sternotomy and is a very elegant, safe, and effective surgical technique, despite its still-limited adoption in the daily toolkit of cardiac surgeons. The goal of this retrospective, single-centre analysis was to evaluate the long-term outcomes of a large patient cohort undergoing MICS CABG. Methods: This study identified 597 consecutive MICS CABG patients from August 2008 to November 2020. We obtained follow-up data by phone or mail. Every patient had a left internal thoracic artery bypass graft. The second and possibly third grafts were radial arteries, great saphenous vein segments, or right internal thoracic arteries. Results: The median age was 69 years, and 92.1% were male. The median EuroSCORE II was 1.5. There were eight conversions to sternotomy and none to cardiopulmonary bypass. The total arterial revascularisation was 92.5%, with 90.3% complete. The 30-day mortality was 0.5%. A total of 575 patients (95.8%) were tracked for 8 years on average. A Cox regression analysis found that a left ventricular ejection fraction < 50%, peripheral vascular disease, chronic kidney disease, and a history of cerebrovascular accident independently predicted severe adverse cardiac and cerebrovascular events and late death. The actuarial survival rates for one, three, five, eight, and ten years were 99%, 95%, 91%, 85%, and 80%, respectively. Conclusions: In our study group, the technique of MICS CABG has been proven to be a safe and effective surgical revascularisation method, with a low rate of early complications and favourable long-term outcomes in eligible patients.
No takes yet. Share an insight, caveat, or question.
Rufa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: